Aripiprazole: Examining the Clinical Implications of D2 Affinity

被引：0
|
作者：
Anam, Adiba [1 ]
Lynch, Sean [1 ]
Mosharraf, Nafiz [1 ]
Soukas, Chloe [1 ]
Gekhman, Dmitriy [1 ,2 ]
机构：
[1] Mt Sinai Beth Israel, Dept Psychiat, New York, NY USA
[2] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA
来源：
CNS SPECTRUMS | 2023年 / 28卷 / 02期
关键词：
D O I：
10.1017/S1092852923001232
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Aripiprazole, a dopamine D2 receptor partial agonist activates nuclear CaMKII in dopaminergic neurons
    Sawai, Masahiro
    Shioda, Norifumi
    Fukunaga, Kohji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 143P - 143P
  • [42] 3-Chlorotyramine Acting as Ligand of the D2 Dopamine Receptor. Molecular Modeling, Synthesis and D2 Receptor Affinity
    Angelina, Emilio
    Andujar, Sebastian
    Moreno, Laura
    Garibotto, Francisco
    Parraga, Javier
    Peruchena, Nelida
    Cabedo, Nuria
    Villecco, Margarita
    Cortes, Diego
    Enriz, Ricardo D.
    MOLECULAR INFORMATICS, 2015, 34 (01) : 28 - 43
  • [43] Switch From Aripiprazole to Full D2 Antagonists Can Lead to a Delay of Their Start of Action
    Marinescu, G. C.
    Popa, S. N.
    Zarioiu, I. C.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [44] Partial D2 agonism and dopaminergic stabilization by aripiprazole -: novel mechanism of action of an atypical neuroleptic
    Müller, WE
    PSYCHOPHARMAKOTHERAPIE, 2002, 9 (04): : 120 - +
  • [45] Dopamine receptor D2 activation suppresses the radiosensitizing effect of aripiprazole via activation of AMPK
    Lee, Hyounji
    Kang, Seongman
    Sonn, Jong Kyung
    Lim, Young-Bin
    FEBS OPEN BIO, 2019, 9 (09): : 1580 - 1588
  • [46] Review article:: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics
    Tonini, M
    Cipollina, L
    Poluzzi, E
    Crema, F
    Corazza, GR
    De Ponti, F
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (04) : 379 - 390
  • [47] Risperidone dopaminergic D2 receptor occupancy and plasma levels over time: Clinical implications.
    Catafau, AM
    Corripio, I
    Martin, JC
    Perez, V
    Tembl, A
    Mari, C
    Estorch, M
    Schotte, A
    Alvarez, E
    Carrio, I
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 204P - 204P
  • [48] In vitro characterisation of the high affinity D2/D3 dopamine agonist (+)PhNO
    Parker, Christine
    Clarke, K.
    Gee, A. D.
    Gee, A.
    Rabiner, E.
    NEUROIMAGE, 2006, 31 : T29 - T29
  • [49] Affinity of dopamine for the D3 and D2 high receptors in the human brain in vivo
    Rabiner, Eugenii
    Shotbolt, Paul
    Tziortzi, Andri
    Searle, Graham
    Laruelle, Marc
    Gunn, Roger
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [50] In Vivo Dopamine D3 and D2 Receptor Occupancy Profile of Cariprazine Versus Aripiprazole: A PET Study
    Girgis, Ragy
    Abi-Dargham, Anissa
    Slifstein, Mark
    Chen, Laishun
    Periclou, Antonia
    Adham, Nika
    Earley, Willie
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S595 - S596
12345